Objective, Investment Banking & Valuation Awarded Industrials Deal of the Year (Over $100MM)
Los Angeles, CA – Objective, Investment Banking & Valuation has been awarded “Industrials Deal of the Year” in the “Deals Over $100 Million” category by The M&A Advisor’s 15th Annual International M&A Awards. This recognition showcases Objective’s ability to navigate and excel in complex, large-scale deals. “The International M&A Awards celebrate the power of global collaboration […]
Trever Acers of Objective, Investment Banking & Valuation recognized as 2024 CEO Visionaries by L.A. Times B2B Publishing’s C-Suite Magazine
Los Angeles, CA – Objective, Investment Banking & Valuation, proudly announces the recognition of Trever Acers as 2024 CEO Visionary by L.A. Times B2B Publishing’s C-Suite Magazine. This esteemed accolade celebrates their exceptional contributions and remarkable achievements over the past 24 months. Click here to read the magazine. At Objective, Trever Acers leads with purpose, […]
“The Advantages of a Private Equity Deal” | Exit Readiness Podcast Featuring Channing Hamlet
Channing Hamlet recently joined an episode of the Exit Readiness Podcast as a guest expert. In this episode “The Advantages of a Private Equity Deal”, Channing highlights the advantages of selling to a private equity firm verses a strategic buyer. Listen to the Full Episode on Apple Podcasts Listen to the Full Episode on Spotify […]
Aerospace & Defense Industry Update | Q2 2024
In this M&D M&A Industry Update, we explore the M&A activity and projections for the Aerospace & Defense area within the M&D industry. Our Manufacturing & Distribution Practice Group experts share their insights on the current state of the Aerospace & Defense M&A market and look at the factors influencing the broader M&D industry. Select Insights: […]
Channing Hamlet Featured In The LA Times Discussing The Healthcare, Biotech, and Life Sciences Landscape in 2024
Los Angeles, CA – July 22, 2024 – We are thrilled to announce that Channing Hamlet, Managing Director, has been featured in the Los Angeles Times as an M&A and Valuation expert in the Life Sciences, Biotech, and Healthcare services industries. The article titled “Robert T. Braithwaite, Channing Hamlet, and Daniel A. Platt Share Insights […]
“The Art of Business Valuation: Keys to Unlocking Cash-Out Opportunities” | Business Growth Architect Featuring Trever Acers
Trever Acers recently joined an episode of Business Growth Architect as a guest expert. In this episode “The Art of Business Valuation: Keys to Unlocking Cash-Out Opportunities”, Trever discusses the quantitative and qualitative features of getting the most out of a business sale. Listen to the Full Episode on Apple Podcasts Listen to the Full […]
Objective, Investment Banking and Valuation Expands Expertise in Aerospace & Defense Under Manufacturing & Distribution Practice
Los Angeles, CA – July 15, 2024 – Objective, Investment Banking and Valuation (“Objective”) is pleased to announce the expansion of its services with the Aerospace & Defense (“A&D”) area of expertise under its Manufacturing & Distribution (“M&D”) Practice. This initiative will be a primary focus of Vice President, Cody McPherson, under the stewardship of […]
Fairness Opinions in Technology Mergers and Acquisitions: Ensuring Equitable Deals
Fairness opinions play a key role in mergers and acquisitions (M&A), particularly within the technology sector. These opinions are independent assessments provided by financial advisors to evaluate whether the terms of a deal are fair from a financial perspective. Fairness opinions are crucial for ensuring that all parties involved, whether that’s sellers, investors, or advisors […]
Healthcare Investment Banking: Valuations, Deals, Industry Outlook
Healthcare investment banking plays a crucial role in the financial ecosystem of the healthcare industry. It involves a range of services, including mergers and acquisitions (M&A), capital raising, and strategic advisory, tailored specifically for healthcare companies. These services help healthcare organizations navigate complex financial landscapes, optimize their financial performance, and achieve strategic objectives. Investment banking […]
Life Sciences & Investment Banking: Valuations, Deals, Industry Outlook
The Life Sciences and Investment Banking sector is defined by rapid technological advancements and regulatory complexities, driving the need for specialized financial expertise. As 2024 progresses, the sector remains a hub of innovation, pushing the boundaries of biotechnology, pharmaceuticals, and medical devices. This environment, while rich in opportunity, presents unique challenges for valuation and strategic […]